BOSTON--(BUSINESS WIRE)--Leuko, an MIT startup developing PointCheck TM, the first solution that enables at-home noninvasive white blood cell (WBC) monitoring, today announced a first closing of $5 ...
BOSTON--(BUSINESS WIRE)--Leuko, an MIT-born technology startup developing the first non-invasive white blood cell monitoring device, today announced it has raised $1.8 million in seed financing from ...
Cancer was estimated to be responsible for more than 18 million cases worldwide in 2020 Leuko, founded by researchers at the Massachusetts Institute of Technology (MIT), has developed an at-home white ...
In a groundbreaking development for cancer treatment, Massachusetts Institute of Technology (MIT) spinoff Leuko has pioneered a device that promises to transform how doctors monitor cancer patients ...
MIT spin-out is developing a microscope platform for label-free imaging of human blood cells as they flow through capillaries. Leuko, a startup company established by researchers at the Massachusetts ...
Leuko, a medtech company pioneering the field of non-invasive blood testing, announced today that it has received a $4.5 million SBIR Phase IIB award from the National Institutes of Health (NIH) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results